Results

1–9 of 9 results for syringe

Treatment Switch From Aflibercept to Ranibizumab Pre-filled Syringe in Canadian nAMD and DME Patients in a Real-World Setting: The PRECISE Study
Ananda Kalevar, MD, FRCS(C), DABO
On Demand Cases, Courses, and Papers
2020
Reduced Incidence of Post-Injection Endophthalmitis With Pre-filled Syringes
Daniel B. Roth, MD
On Demand Cases, Courses, and Papers
2020
Agitation of the Syringe as a Cause of Inflammation After Intravitreal Injection of Aflibercept: A Randomized, Double-blind, Controlled Clinical Trial
Gustavo Barreto de Melo, MD, PhD, FASRS
Annual Meeting Talks
2020
Particulate Matter From Syringes Used for Intravitreal Injections
Roger A. Goldberg, MD, MBA
Annual Meeting Talks
2020
Silicone Droplets are Released by Syringes and Found in the Vitreous
Gustavo Barreto de Melo, MD, PhD, FASRS
Annual Meeting Talks
2019
Endophthalmitis Rates of Prefilled Ranibizumab Syringes Compared to Conventional Ranibizumab Vials: An International Multicenter Study
Yoshihiro Yonekawa, MD, FASRS
Annual Meeting Talks
2018
Inflammation After Aflibercept Injection in Association With a Specific Brand of Syringe That Releases Silicone Oil Droplets A Case-Control Study
Gustavo Barreto de Melo, MD, PhD, FASRS
Annual Meeting Talks
2018
Episode 157: March Retinal Physician Review with Dr. Shriji Patel including discussion of complement inhibition for AMD, faricimab, brolucizimab, and prefilled syringes for injectable medications
Jayanth Sridhar, MD
Member Podcasts
2018
Silicone Oil (SO) Microdroplets in Repackaged Bevacizumab Syringes: Identification, Quantification, and Strategies For Reducing Clincal Impact
John D Pitcher, MD
On Demand Cases, Courses, and Papers
2017